Globus Medical (GMED) FCF Margin (2011 - 2026)

Globus Medical has reported FCF Margin for 16 years, with the latest figure at 21.42% in Q1 2026.

• For the quarter ending Q1 2026, FCF Margin fell 219.0% year-over-year to 21.42%; the trailing twelve-month figure through Mar 2026 stood at 19.68% (down 21.0% YoY), and the FY2025 full-year result was 20.03%, up 395.0% from the prior year.
• FCF Margin for Q1 2026 stood at 21.42%, up from 11.78% in the prior quarter.
• The five-year high for FCF Margin was 41.47% in Q3 2025, with the low at 6.99% in Q3 2022.
• Historically, FCF Margin has averaged 16.1% across 5 years, with a median of 13.64% in 2022.
• Annual changes were most pronounced in 2022 — FCF Margin slumped 4064 bps — and 2024, when it soared 2572 bps.
• Globus Medical's FCF Margin stood at 40.9% in 2022, then plunged by 68 bps to 13.27% in 2023, then jumped by 122 bps to 29.4% in 2024, then sank by 60 bps to 11.78% in 2025, then surged by 82 bps to 21.42% in 2026.
• The last three FCF Margin figures came in at 21.42% (Q1 2026), 11.78% (Q4 2025), and 41.47% (Q3 2025), per Business Quant data.